Patients who resume oral anticoagulation treatment following intracerebral hemorrhage (ICH) are almost twice as likely to achieve functional recovery, according to a study published Oct. 9 in Stroke.
Thumbnail
Harvard Medical School and Brigham and Women’s Hospital are recommending 31 papers authored by a…
Thumbnail
Women with a history of cardiotoxicity from previous cancer treatments are around 30 percent more…
Thumbnail
Despite the myth of a “weekend effect” in cardiac surgery—the idea that patients discharged from…
Thumbnail
CMS is reconsidering its reimbursement practices for ambulatory blood pressure monitoring (ABPM) at…
Thumbnail
Cardiovascular disease remains the world’s No. 1 killer, responsible for a third of global deaths…
Thumbnail
Robert B. Ford has been named president and chief operating officer of Abbott, the company…
Thumbnail
Heart valve surgery patients, including those who undergo aortic and mitral interventions, are at…
Thumbnail
Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker…
Thumbnail
Indian-American cardiologist and serial entrepreneur Kiran Patel this week announced he’s investing…
Thumbnail
Experienced operators in Europe are treating chronic total occlusions (CTOs) with increasing…
Thumbnail
The shorter a patient’s hospital stay after elective percutaneous coronary intervention (PCI), the…
Thumbnail
Cystatin C (Cys-C), an alternative to renal markers like creatinine and glomerular filtration rate…